Biogen Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $5.95B | $11.48B | $924.0M |
| Jun 2017 | $5.95B | $11.59B | $1.17B |
| Sep 2017 | $5.94B | $12.86B | $1.55B |
| Dec 2017 | $5.94B | $12.61B | $1.57B |
| Mar 2018 | $5.93B | $14.05B | $4.11B |
| Jun 2018 | $5.93B | $12.26B | $1.25B |
| Sep 2018 | $5.93B | $13.77B | $2.39B |
| Dec 2018 | $5.94B | $13.04B | $1.22B |
| Mar 2019 | $5.94B | $13.83B | $2.24B |
| Jun 2019 | $5.95B | $12.95B | $1.72B |
| Sep 2019 | $4.46B | $14.00B | $2.34B |
| Dec 2019 | $4.46B | $13.34B | $2.91B |
| Mar 2020 | $4.46B | $12.55B | $2.59B |
| Jun 2020 | $7.42B | $11.31B | $2.38B |
| Sep 2020 | $7.43B | $10.76B | $2.22B |
| Dec 2020 | $7.43B | $10.70B | $1.33B |
| Mar 2021 | $7.27B | $10.68B | $1.22B |
| Jun 2021 | $7.27B | $10.75B | $1.74B |
| Sep 2021 | $6.27B | $10.43B | $1.54B |
| Dec 2021 | $6.27B | $10.90B | $2.26B |
| Mar 2022 | $6.28B | $11.24B | $1.75B |
| Jun 2022 | $6.28B | $11.87B | $2.65B |
| Sep 2022 | $6.28B | $12.78B | $3.68B |
| Dec 2022 | $6.28B | $13.40B | $3.42B |
| Mar 2023 | $6.28B | $13.80B | $2.90B |
| Jun 2023 | $6.28B | $14.47B | $2.62B |
| Sep 2023 | $6.79B | $14.48B | $2.29B |
| Dec 2023 | $6.79B | $14.80B | $1.05B |
| Mar 2024 | $6.29B | $15.21B | $1.07B |
| Jun 2024 | $6.29B | $15.89B | $1.91B |
| Sep 2024 | $4.55B | $16.36B | $1.70B |
| Dec 2024 | $4.55B | $16.72B | $2.38B |
| Mar 2025 | $4.55B | $16.98B | $2.60B |
| Jun 2025 | $6.28B | $17.63B | $2.76B |
| Sep 2025 | $6.29B | $18.21B | $3.86B |
| Dec 2025 | $6.29B | $18.26B | $3.01B |
| Mar 2026 | $6.29B | $18.65B | $3.38B |